SlideShare ist ein Scribd-Unternehmen logo

Hcls call september 2013 clinical pharmacogenomics

•Als PPTX, PDF herunterladen•
•
Matthias Samwald
Matthias Samwald
1 von 2
Clinical Pharmacogenomics – the past year • Prototype of ontology (new release upcoming) – On the cutting edge of OWL reasoner technology • Prototype of Medine Safety Code system • RDF representation of PGx statements in drug labels • Improvement to contents in Bio2RDF • Significant academic output in international conferences and peer-reviewed journals
Clinical Pharmacogenomics – the next year • From research prototype to version 1.0 (update knowledge base, cover more data, ensure stability and sustainability) • Establish collaboration with clinical PGx projects (such as PGRNseq) • Evaluation in realistic settings, incremental improvement based on feedback • Detailed schedule at http://www.w3.org/wiki/HCLSIG/Pharmacogeno mics#Schedule

Empfohlen

Vaccine security Meeting - Perspective on challenges oie - M.Stone
Vaccine security Meeting - Perspective on challenges oie - M.StoneVaccine security Meeting - Perspective on challenges oie - M.Stone
Vaccine security Meeting - Perspective on challenges oie - M.StoneEuFMD
 
HCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka MalmHCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka MalmChemicals Forum Association
 
21st Century Manufacturing of Injectable Pharmaceuticals
21st Century Manufacturing of Injectable Pharmaceuticals21st Century Manufacturing of Injectable Pharmaceuticals
21st Century Manufacturing of Injectable PharmaceuticalsVanrx Pharmasystems
 
June 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne GourmelonJune 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne GourmelonChemicals Forum Association
 
June 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika KunzJune 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika KunzChemicals Forum Association
 
Go to the market
Go to the marketGo to the market
Go to the marketProFAX
 
HCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De SchamphelaereHCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De SchamphelaereChemicals Forum Association
 
Vaccines
VaccinesVaccines
VaccinesCreative Biolabs
 

Empfohlen

Vaccine security Meeting - Perspective on challenges oie - M.Stone
Vaccine security Meeting - Perspective on challenges oie - M.StoneVaccine security Meeting - Perspective on challenges oie - M.Stone
Vaccine security Meeting - Perspective on challenges oie - M.StoneEuFMD
 
HCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka MalmHCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka MalmChemicals Forum Association
 
21st Century Manufacturing of Injectable Pharmaceuticals
21st Century Manufacturing of Injectable Pharmaceuticals21st Century Manufacturing of Injectable Pharmaceuticals
21st Century Manufacturing of Injectable PharmaceuticalsVanrx Pharmasystems
 
June 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne GourmelonJune 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne GourmelonChemicals Forum Association
 
June 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika KunzJune 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika KunzChemicals Forum Association
 
Go to the market
Go to the marketGo to the market
Go to the marketProFAX
 
HCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De SchamphelaereHCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De SchamphelaereChemicals Forum Association
 
Vaccines
VaccinesVaccines
VaccinesCreative Biolabs
 
HCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas BallHCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas BallChemicals Forum Association
 
End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...
End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...
End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...Covance
 
HCF 2019 Panel 5: Bob Diderich
HCF 2019 Panel 5: Bob DiderichHCF 2019 Panel 5: Bob Diderich
HCF 2019 Panel 5: Bob DiderichChemicals Forum Association
 
Measuring Medicine Prices
Measuring Medicine PricesMeasuring Medicine Prices
Measuring Medicine PricesMeTApresents
 
The Biotechnology Program at Montgomery College
The Biotechnology Program at Montgomery CollegeThe Biotechnology Program at Montgomery College
The Biotechnology Program at Montgomery CollegeSamDaly8
 
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...Canadian Organization for Rare Disorders
 
HCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de BruijnHCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de BruijnChemicals Forum Association
 
HCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren KellandHCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren KellandChemicals Forum Association
 
Vaccine security meeting - development amnd perspectives - D.John
Vaccine security meeting - development amnd perspectives - D.JohnVaccine security meeting - development amnd perspectives - D.John
Vaccine security meeting - development amnd perspectives - D.JohnEuFMD
 
HCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco CamboniHCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco CamboniChemicals Forum Association
 
June 9 2017 Panel 4 Brian Richards
June 9 2017 Panel 4 Brian RichardsJune 9 2017 Panel 4 Brian Richards
June 9 2017 Panel 4 Brian RichardsChemicals Forum Association
 
Food Safety: Feedback from breakout session to plenary
Food Safety: Feedback from breakout session to plenary Food Safety: Feedback from breakout session to plenary
Food Safety: Feedback from breakout session to plenary Independent Science and Partnership Council of the CGIAR
 
Alignment and harmonisation in R4H
Alignment and harmonisation in R4HAlignment and harmonisation in R4H
Alignment and harmonisation in R4Hcohred_web4d
 
HCF 2017 closing day 1 Jukka Malm
HCF 2017 closing day 1 Jukka MalmHCF 2017 closing day 1 Jukka Malm
HCF 2017 closing day 1 Jukka MalmChemicals Forum Association
 
Joseph Levy MedicReS World Congress 2013 - 2
Joseph Levy MedicReS World Congress 2013 - 2Joseph Levy MedicReS World Congress 2013 - 2
Joseph Levy MedicReS World Congress 2013 - 2MedicReS
 
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...Richard Boyce, PhD
 
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...Ryan Squire
 
Keynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidenceKeynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidenceRichard Boyce, PhD
 
Pharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesPharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesRyan Squire
 
Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...John Cai
 
AkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aAkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aYawo Akrodou
 
Problems facing the pharmaceutical industry
Problems facing the pharmaceutical industryProblems facing the pharmaceutical industry
Problems facing the pharmaceutical industryKelly To
 

Weitere ähnliche Inhalte

Was ist angesagt?

End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...
End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...
End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...Covance
 
Measuring Medicine Prices
Measuring Medicine PricesMeasuring Medicine Prices
Measuring Medicine PricesMeTApresents
 
The Biotechnology Program at Montgomery College
The Biotechnology Program at Montgomery CollegeThe Biotechnology Program at Montgomery College
The Biotechnology Program at Montgomery CollegeSamDaly8
 
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...Canadian Organization for Rare Disorders
 
Vaccine security meeting - development amnd perspectives - D.John
Vaccine security meeting - development amnd perspectives - D.JohnVaccine security meeting - development amnd perspectives - D.John
Vaccine security meeting - development amnd perspectives - D.JohnEuFMD
 
Alignment and harmonisation in R4H
Alignment and harmonisation in R4HAlignment and harmonisation in R4H
Alignment and harmonisation in R4Hcohred_web4d
 

Was ist angesagt? (14)

HCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas BallHCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas Ball
 
End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...
End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...
End-to-End Drug & Diagnostic Development Support for a New Immuno-Oncology Ag...
 
HCF 2019 Panel 5: Bob Diderich
HCF 2019 Panel 5: Bob DiderichHCF 2019 Panel 5: Bob Diderich
HCF 2019 Panel 5: Bob Diderich
 
Measuring Medicine Prices
Measuring Medicine PricesMeasuring Medicine Prices
Measuring Medicine Prices
 
The Biotechnology Program at Montgomery College
The Biotechnology Program at Montgomery CollegeThe Biotechnology Program at Montgomery College
The Biotechnology Program at Montgomery College
 
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...
PharmaDiplomacy: Principles for Collaborative Mutually Acceptable Drug Prici...
 
HCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de BruijnHCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de Bruijn
 
HCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren KellandHCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren Kelland
 
Vaccine security meeting - development amnd perspectives - D.John
Vaccine security meeting - development amnd perspectives - D.JohnVaccine security meeting - development amnd perspectives - D.John
Vaccine security meeting - development amnd perspectives - D.John
 
HCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco CamboniHCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco Camboni
 
June 9 2017 Panel 4 Brian Richards
June 9 2017 Panel 4 Brian RichardsJune 9 2017 Panel 4 Brian Richards
June 9 2017 Panel 4 Brian Richards
 
Food Safety: Feedback from breakout session to plenary
Food Safety: Feedback from breakout session to plenary Food Safety: Feedback from breakout session to plenary
Food Safety: Feedback from breakout session to plenary
 
Alignment and harmonisation in R4H
Alignment and harmonisation in R4HAlignment and harmonisation in R4H
Alignment and harmonisation in R4H
 
HCF 2017 closing day 1 Jukka Malm
HCF 2017 closing day 1 Jukka MalmHCF 2017 closing day 1 Jukka Malm
HCF 2017 closing day 1 Jukka Malm
 

Andere mochten auch

Joseph Levy MedicReS World Congress 2013 - 2
Joseph Levy MedicReS World Congress 2013 - 2Joseph Levy MedicReS World Congress 2013 - 2
Joseph Levy MedicReS World Congress 2013 - 2MedicReS
 
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...Richard Boyce, PhD
 
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...Ryan Squire
 
Keynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidenceKeynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidenceRichard Boyce, PhD
 
Pharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesPharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesRyan Squire
 
Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...John Cai
 
AkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aAkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aYawo Akrodou
 
Problems facing the pharmaceutical industry
Problems facing the pharmaceutical industryProblems facing the pharmaceutical industry
Problems facing the pharmaceutical industryKelly To
 

Andere mochten auch (8)

Joseph Levy MedicReS World Congress 2013 - 2
Joseph Levy MedicReS World Congress 2013 - 2Joseph Levy MedicReS World Congress 2013 - 2
Joseph Levy MedicReS World Congress 2013 - 2
 
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
 
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...
Pharmacogenomics in Clinical Medicine: What Is FDA Doing to Facilitate the M...
 
Keynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidenceKeynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidence
 
Pharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesPharmacogenomic Clinical Studies
Pharmacogenomic Clinical Studies
 
Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...
 
AkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aAkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2a
 
Problems facing the pharmaceutical industry
Problems facing the pharmaceutical industryProblems facing the pharmaceutical industry
Problems facing the pharmaceutical industry
 

Mehr von Matthias Samwald

Towards Transformative Artificial Intelligence in Life Science and Health Care
Towards Transformative Artificial Intelligence in Life Science and Health CareTowards Transformative Artificial Intelligence in Life Science and Health Care
Towards Transformative Artificial Intelligence in Life Science and Health CareMatthias Samwald
 
Bridging theory and practice: Clinical decision support systems for personali...
Bridging theory and practice: Clinical decision support systems for personali...Bridging theory and practice: Clinical decision support systems for personali...
Bridging theory and practice: Clinical decision support systems for personali...Matthias Samwald
 
CRISPR as a potential tool for malaria eradication
CRISPR as a potential tool for malaria eradicationCRISPR as a potential tool for malaria eradication
CRISPR as a potential tool for malaria eradicationMatthias Samwald
 
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...One man's *1 is another man's *13? Trouble with nomenclatures in personalized...
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...Matthias Samwald
 
VO Taxonomie und Ontologie (SS 2016)
VO Taxonomie und Ontologie (SS 2016)VO Taxonomie und Ontologie (SS 2016)
VO Taxonomie und Ontologie (SS 2016)Matthias Samwald
 
The FindMeEvidence project: An open-source, mobile-friendly search engine for...
The FindMeEvidence project: An open-source, mobile-friendly search engine for...The FindMeEvidence project: An open-source, mobile-friendly search engine for...
The FindMeEvidence project: An open-source, mobile-friendly search engine for...Matthias Samwald
 
The Medication Safety Code initiative: Towards a global IT system for persona...
The Medication Safety Code initiative: Towards a global IT system for persona...The Medication Safety Code initiative: Towards a global IT system for persona...
The Medication Safety Code initiative: Towards a global IT system for persona...Matthias Samwald
 
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...Matthias Samwald
 
Genomic CDS: an example of a complex ontology for pharmacogenetics and clinic...
Genomic CDS: an example of a complex ontology for pharmacogenetics and clinic...Genomic CDS: an example of a complex ontology for pharmacogenetics and clinic...
Genomic CDS: an example of a complex ontology for pharmacogenetics and clinic...Matthias Samwald
 

Mehr von Matthias Samwald (12)

Towards Transformative Artificial Intelligence in Life Science and Health Care
Towards Transformative Artificial Intelligence in Life Science and Health CareTowards Transformative Artificial Intelligence in Life Science and Health Care
Towards Transformative Artificial Intelligence in Life Science and Health Care
 
Bridging theory and practice: Clinical decision support systems for personali...
Bridging theory and practice: Clinical decision support systems for personali...Bridging theory and practice: Clinical decision support systems for personali...
Bridging theory and practice: Clinical decision support systems for personali...
 
CRISPR as a potential tool for malaria eradication
CRISPR as a potential tool for malaria eradicationCRISPR as a potential tool for malaria eradication
CRISPR as a potential tool for malaria eradication
 
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...One man's *1 is another man's *13? Trouble with nomenclatures in personalized...
One man's *1 is another man's *13? Trouble with nomenclatures in personalized...
 
VO Taxonomie und Ontologie (SS 2016)
VO Taxonomie und Ontologie (SS 2016)VO Taxonomie und Ontologie (SS 2016)
VO Taxonomie und Ontologie (SS 2016)
 
6 Worlds Collide
6 Worlds Collide6 Worlds Collide
6 Worlds Collide
 
The FindMeEvidence project: An open-source, mobile-friendly search engine for...
The FindMeEvidence project: An open-source, mobile-friendly search engine for...The FindMeEvidence project: An open-source, mobile-friendly search engine for...
The FindMeEvidence project: An open-source, mobile-friendly search engine for...
 
The Medication Safety Code initiative: Towards a global IT system for persona...
The Medication Safety Code initiative: Towards a global IT system for persona...The Medication Safety Code initiative: Towards a global IT system for persona...
The Medication Safety Code initiative: Towards a global IT system for persona...
 
Samwald ore 2014
Samwald ore 2014Samwald ore 2014
Samwald ore 2014
 
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
 
Genomic CDS: an example of a complex ontology for pharmacogenetics and clinic...
Genomic CDS: an example of a complex ontology for pharmacogenetics and clinic...Genomic CDS: an example of a complex ontology for pharmacogenetics and clinic...
Genomic CDS: an example of a complex ontology for pharmacogenetics and clinic...
 
Samwald cshals2013
Samwald cshals2013Samwald cshals2013
Samwald cshals2013
 

Hcls call september 2013 clinical pharmacogenomics

  • 1. Clinical Pharmacogenomics – the past year • Prototype of ontology (new release upcoming) – On the cutting edge of OWL reasoner technology • Prototype of Medine Safety Code system • RDF representation of PGx statements in drug labels • Improvement to contents in Bio2RDF • Significant academic output in international conferences and peer-reviewed journals
  • 2. Clinical Pharmacogenomics – the next year • From research prototype to version 1.0 (update knowledge base, cover more data, ensure stability and sustainability) • Establish collaboration with clinical PGx projects (such as PGRNseq) • Evaluation in realistic settings, incremental improvement based on feedback • Detailed schedule at http://www.w3.org/wiki/HCLSIG/Pharmacogeno mics#Schedule